SlideShare a Scribd company logo
Gary Oh
 Blood tests commonly obtained to evaluate the health of the liver include:
 Liver enzyme levels (ALT/AST)
 Hepatic synthetic function (Albumin/PT/PTT)
 Serum bilirubin level (Conjugated and Unconjugated bilirubin).
 Elevated liver enzymes reflect damage to liver or biliary tree obstruction
 Abnormal serum albumin or prothrombin time may be seen in the setting of
impaired hepatic synthetic function.
 Serum bilirubin partly measures liver's ability to detoxify metabolites and
transport organic anions into bile.
 Alanine aminotransferase (ALT):
• Male: 10 to 55 int. unit/L
• Female: 7 to 30 int. unit/L
 Aspartate aminotransferase (AST):
• Male: 10 to 40 int. unit/L
• Female: 9 to 32 int. unit/L
Liver Enzymes
Serum aminotransferases:
alanine aminotransferase (ALT, formerly called SGPT)
aspartate aminotransferase (AST, formerly called
SGOT)
Alkaline phosphatase (Alk Phos)
Gamma-glutamyl transpeptidase (GGT)
5'-nucleotidase
Lactate dehydrogenase (LDH)
First step is transamination, where amino group is
transferred a-KG
Products are alpha-keto acid (derived from the original
amino acid) and glutamate.
Glutamate produced by transamination can be oxidatively
deaminated, or used as an amino group donor in the
synthesis of nonessential amino acids.
Transaminases are in the cytosol and mitochondria of cells
throughout the body – (esp: liver, kidney, intestine, and
muscle).
All amino acids, with the exception of lysine and
threonine, participate in transamination at some point in
their catabolism.
 Substrate specificity of aminotransferases:
 Aminotransferases are named after the specific amino group donor,
 Acceptor of the amino group is almost always a-KG.
 Two most important aminotransferase reactions are catalyzed by alanine
aminotransferase (ALT) and aspartate aminotransferase(AST
 Alanine aminotransferase (ALT) (glutamate-pyruvate transaminase)
 ALT is present in many tissues. HOWEVER IT IS SPECIFIC FOR LIVER (unlike
AST which is present in many tissues including muscle). THUS elevations in
ALT are more specific for liver than AST.
 Catalyzes transfer of the amino group of alanine to a-KG, resulting in the
formation of pyruvate and glutamate.
 Reversible
 During amino acid catabolism, this enzyme functions in the direction of
glutamate synthesis.
 Glutamate, in effect, acts as a “collector” of nitrogen from alanine.
 Transfer of amino group between alanine and alpha keto acid forming
Pyruvate and Glutamate
Aspartate aminotransferase (AST):
AST is an exception to the rule that aminotransferases
direct amino groups to form glutamate.
AST transfers amino groups from glutamate to
oxaloacetate (forming aspartate), which is used as a
source of nitrogen in the urea cycle.
Reversible
Transfer of amino group between aspartate and alpha
keto acid forming OA and Glutamate.
Aspartate used in the urea cycle.
Liver Disease
Aminotransferases are intracellular enzymes
Low levels found in the plasma represent the release
of cellular contents during normal cell turnover.
Elevated plasma levels of aminotransferases indicates
damage to cells rich in these enzymes.
AST:ALT Ratio
Most causes of hepatocellular injury are associated with an AST that is
lower than the ALT.
Normal AST/ALT is 1.3
AST to ALT ratio of 2:1 or greater suggests alcoholic liver disease,
particularly in the setting of an elevated GGT.
Nonalcoholic steatohepatitis - AST to ALT ratio is elevated in an
alcoholic liver disease pattern in patients
Alcoholic liver disease – Elevated
Hepatitis C - Elevated
In addition, patients with Wilson disease or cirrhosis (viral hepatitis)
may have AST>ALT, though in patients with cirrhosis the ratio
typically is not greater than two.
Magnitude of AST and ALT elevations
 Magnitude of AST and ALT elevations varies due to cause of hepatocellular
injury
 Alcoholic fatty liver disease: AST <8 times the upper limit of normal; ALT <5
times the upper limit of normal
 Nonalcoholic fatty liver disease: AST and ALT <4 times the upper limit of
normal
 Ischemic hepatopathy (ischemic hepatitis, shock liver): AST and ALT >50
times the upper limit of normal (in addition the lactate dehydrogenase is often
markedly elevated)
 Acute viral hepatitis or toxin-related hepatitis with jaundice: AST and ALT >25
times upper limit of normal
 Chronic hepatitis C: Wide variability, typically normal to less than twice the
upper limit of normal, rarely more than 10 times the upper limit of normal
 Chronic hepatitis B: Levels fluctuate; the AST and ALT may be normal, though
most patients have mild to moderate elevations (approximately twice the
upper limit of normal); with exacerbations, levels are more than 10 times the
upper limit of normal
References
 Cohen JA, Kaplan MM. The SGOT/SGPT ratio--an indicator of alcoholic liver disease.
Dig Dis Sci 1979;
 Fuchs S, Bogomolski-Yahalom V, Paltiel O, Ackerman Z. Ischemic hepatitis: clinical and
laboratory observations of 34 patients. J Clin Gastroenterol 1998; 26:183
 Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am J Gastroenterol 1992;
87:831.
 Henrion J, Schapira M, Luwaert R, et al. Hypoxic hepatitis: clinical and hemodynamic
study in 142 consecutive cases. Medicine (Baltimore) 2003; 82:392.
 Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45:507
 Ruhl CE, Everhart JE. Upper limits of normal for alanine aminotransferase activity in the
United States population. Hepatology 2012; 55:447.

More Related Content

What's hot

PANCREATIC FUNCTION TESTS
PANCREATIC FUNCTION TESTSPANCREATIC FUNCTION TESTS
PANCREATIC FUNCTION TESTS
YESANNA
 

What's hot (20)

sgot and sgpt
sgot and sgptsgot and sgpt
sgot and sgpt
 
creatinine clearance test
creatinine clearance testcreatinine clearance test
creatinine clearance test
 
ISOENZYMES & CLINICAL ENZYMOLOGY
ISOENZYMES & CLINICAL ENZYMOLOGYISOENZYMES & CLINICAL ENZYMOLOGY
ISOENZYMES & CLINICAL ENZYMOLOGY
 
liver enzymes markers.pptx
liver enzymes markers.pptxliver enzymes markers.pptx
liver enzymes markers.pptx
 
PANCREATIC FUNCTION TESTS
PANCREATIC FUNCTION TESTSPANCREATIC FUNCTION TESTS
PANCREATIC FUNCTION TESTS
 
Tests for pancreatic and intestinal functions
Tests for pancreatic and intestinal functionsTests for pancreatic and intestinal functions
Tests for pancreatic and intestinal functions
 
Liver Function Test
Liver Function TestLiver Function Test
Liver Function Test
 
Pancreatic function tests
Pancreatic function testsPancreatic function tests
Pancreatic function tests
 
creatinine
creatininecreatinine
creatinine
 
kidney function tests
kidney function testskidney function tests
kidney function tests
 
Ast(aspartate transaminase
Ast(aspartate transaminaseAst(aspartate transaminase
Ast(aspartate transaminase
 
LIVER FUNCTIONS TESTS -1-
LIVER FUNCTIONS TESTS -1-LIVER FUNCTIONS TESTS -1-
LIVER FUNCTIONS TESTS -1-
 
Renal function tests
Renal function testsRenal function tests
Renal function tests
 
Renal Function Test
Renal Function TestRenal Function Test
Renal Function Test
 
Renal function tests
Renal function testsRenal function tests
Renal function tests
 
Clinical enzymology final.15.1.14
Clinical enzymology final.15.1.14Clinical enzymology final.15.1.14
Clinical enzymology final.15.1.14
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Metabolism of bilurubin
Metabolism of bilurubinMetabolism of bilurubin
Metabolism of bilurubin
 
urea, creatinine,inulin clearance test.pptx
urea, creatinine,inulin clearance test.pptxurea, creatinine,inulin clearance test.pptx
urea, creatinine,inulin clearance test.pptx
 

Viewers also liked

Zoulim du 2012
Zoulim du 2012Zoulim du 2012
Zoulim du 2012
odeckmyn
 
Lab diagnosis in alcoholic liver disease
Lab diagnosis in alcoholic liver diseaseLab diagnosis in alcoholic liver disease
Lab diagnosis in alcoholic liver disease
Prateek Singh
 
Graphene mobile phone
Graphene mobile phoneGraphene mobile phone
Graphene mobile phone
Nalini Anand
 
Nobel Prize
Nobel PrizeNobel Prize
Nobel Prize
rajasv
 
Amino Acid Catabolism 2
Amino Acid Catabolism 2Amino Acid Catabolism 2
Amino Acid Catabolism 2
Yavuz Yildirim
 

Viewers also liked (19)

ELEVATED SERUM AMINOTRANSFERASES
ELEVATED SERUM AMINOTRANSFERASESELEVATED SERUM AMINOTRANSFERASES
ELEVATED SERUM AMINOTRANSFERASES
 
The 2012 Nobel Laureates
The 2012 Nobel LaureatesThe 2012 Nobel Laureates
The 2012 Nobel Laureates
 
Ast e alt
Ast e altAst e alt
Ast e alt
 
Zoulim du 2012
Zoulim du 2012Zoulim du 2012
Zoulim du 2012
 
Lab diagnosis in alcoholic liver disease
Lab diagnosis in alcoholic liver diseaseLab diagnosis in alcoholic liver disease
Lab diagnosis in alcoholic liver disease
 
Nobel Prize
Nobel PrizeNobel Prize
Nobel Prize
 
Chapter31.liver
Chapter31.liverChapter31.liver
Chapter31.liver
 
Common liver problems for extern
Common liver problems for externCommon liver problems for extern
Common liver problems for extern
 
Graphene mobile phone
Graphene mobile phoneGraphene mobile phone
Graphene mobile phone
 
Enzymes For Medical Students
Enzymes For Medical StudentsEnzymes For Medical Students
Enzymes For Medical Students
 
Hemolytic Disease of the newborn ( RH Isoimmunization )
Hemolytic Disease of the newborn ( RH Isoimmunization )Hemolytic Disease of the newborn ( RH Isoimmunization )
Hemolytic Disease of the newborn ( RH Isoimmunization )
 
biological markers
biological markersbiological markers
biological markers
 
Nobel Prize
Nobel PrizeNobel Prize
Nobel Prize
 
Top 10 Inspirational Quotes from Nobel Prize winners
Top 10 Inspirational Quotes from Nobel Prize winnersTop 10 Inspirational Quotes from Nobel Prize winners
Top 10 Inspirational Quotes from Nobel Prize winners
 
Molecular mechanism of drug induced hepatotoxicity
Molecular mechanism of drug induced hepatotoxicityMolecular mechanism of drug induced hepatotoxicity
Molecular mechanism of drug induced hepatotoxicity
 
Liver function test
Liver function testLiver function test
Liver function test
 
Abnormal liver function tests
Abnormal liver function testsAbnormal liver function tests
Abnormal liver function tests
 
Amino Acid Catabolism 2
Amino Acid Catabolism 2Amino Acid Catabolism 2
Amino Acid Catabolism 2
 
Biochemical markers
Biochemical markersBiochemical markers
Biochemical markers
 

Similar to Biochemical markers in diagnosis of Liver DIsease

Correlation Of Alpha Fetoprotein & Lf Ts In Liver
Correlation Of Alpha Fetoprotein & Lf Ts In LiverCorrelation Of Alpha Fetoprotein & Lf Ts In Liver
Correlation Of Alpha Fetoprotein & Lf Ts In Liver
Zahoor Ahmed
 
Chemistry2009 Laboratory
Chemistry2009 LaboratoryChemistry2009 Laboratory
Chemistry2009 Laboratory
Miami Dade
 

Similar to Biochemical markers in diagnosis of Liver DIsease (20)

liver enzymes.docx
liver enzymes.docxliver enzymes.docx
liver enzymes.docx
 
LFT.pptx
LFT.pptxLFT.pptx
LFT.pptx
 
liver function test
liver function testliver function test
liver function test
 
ABNORMAL LFT.ppt
ABNORMAL LFT.pptABNORMAL LFT.ppt
ABNORMAL LFT.ppt
 
Approach to patients with high liver function test
Approach to patients with high liver function testApproach to patients with high liver function test
Approach to patients with high liver function test
 
Correlation Of Alpha Fetoprotein & Lf Ts In Liver
Correlation Of Alpha Fetoprotein & Lf Ts In LiverCorrelation Of Alpha Fetoprotein & Lf Ts In Liver
Correlation Of Alpha Fetoprotein & Lf Ts In Liver
 
Liver function tests final
Liver function tests finalLiver function tests final
Liver function tests final
 
LIVER FUNCTIONS TESTS -2-
LIVER FUNCTIONS TESTS -2-LIVER FUNCTIONS TESTS -2-
LIVER FUNCTIONS TESTS -2-
 
Liver Tests
Liver TestsLiver Tests
Liver Tests
 
share.pptx
share.pptxshare.pptx
share.pptx
 
liver_function_test_2018.pptx
liver_function_test_2018.pptxliver_function_test_2018.pptx
liver_function_test_2018.pptx
 
Liver Functions tests
Liver Functions testsLiver Functions tests
Liver Functions tests
 
Liver function test.pptx
Liver function test.pptxLiver function test.pptx
Liver function test.pptx
 
LIVER FUNCTION TEST (ENZYME PART)
LIVER FUNCTION TEST (ENZYME PART)LIVER FUNCTION TEST (ENZYME PART)
LIVER FUNCTION TEST (ENZYME PART)
 
A batch 1 st group
A batch 1 st groupA batch 1 st group
A batch 1 st group
 
LIVER FUNCTION TEST
LIVER FUNCTION TEST LIVER FUNCTION TEST
LIVER FUNCTION TEST
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
LIVER FUNCTION TESTS from Millers Anesthesia
LIVER FUNCTION TESTS from Millers Anesthesia LIVER FUNCTION TESTS from Millers Anesthesia
LIVER FUNCTION TESTS from Millers Anesthesia
 
Chemistry2009 Laboratory
Chemistry2009 LaboratoryChemistry2009 Laboratory
Chemistry2009 Laboratory
 
Liver Disease
Liver DiseaseLiver Disease
Liver Disease
 

More from Chee Oh (11)

Malignant Hyperthermia
Malignant HyperthermiaMalignant Hyperthermia
Malignant Hyperthermia
 
Neuropeptide Y
Neuropeptide YNeuropeptide Y
Neuropeptide Y
 
Factor 3 and 7
Factor 3 and 7Factor 3 and 7
Factor 3 and 7
 
Biochemical markers in diagnosis of kidney disease
Biochemical markers in diagnosis of kidney diseaseBiochemical markers in diagnosis of kidney disease
Biochemical markers in diagnosis of kidney disease
 
Fanconi’s Anemia
Fanconi’s AnemiaFanconi’s Anemia
Fanconi’s Anemia
 
Lambert Eaton Myasthenic Syndrome (LEMS)
Lambert Eaton Myasthenic Syndrome (LEMS)Lambert Eaton Myasthenic Syndrome (LEMS)
Lambert Eaton Myasthenic Syndrome (LEMS)
 
Botulism
BotulismBotulism
Botulism
 
Horner's Syndrome
Horner's SyndromeHorner's Syndrome
Horner's Syndrome
 
Spina Bifida
Spina BifidaSpina Bifida
Spina Bifida
 
Hydrocephalus
HydrocephalusHydrocephalus
Hydrocephalus
 
Chronic Traumatic Encephalopathy
Chronic Traumatic EncephalopathyChronic Traumatic Encephalopathy
Chronic Traumatic Encephalopathy
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 

Recently uploaded (20)

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Fundamental of Radiobiology -SABBU.pptx
Fundamental of Radiobiology  -SABBU.pptxFundamental of Radiobiology  -SABBU.pptx
Fundamental of Radiobiology -SABBU.pptx
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 

Biochemical markers in diagnosis of Liver DIsease

  • 2.  Blood tests commonly obtained to evaluate the health of the liver include:  Liver enzyme levels (ALT/AST)  Hepatic synthetic function (Albumin/PT/PTT)  Serum bilirubin level (Conjugated and Unconjugated bilirubin).  Elevated liver enzymes reflect damage to liver or biliary tree obstruction  Abnormal serum albumin or prothrombin time may be seen in the setting of impaired hepatic synthetic function.  Serum bilirubin partly measures liver's ability to detoxify metabolites and transport organic anions into bile.  Alanine aminotransferase (ALT): • Male: 10 to 55 int. unit/L • Female: 7 to 30 int. unit/L  Aspartate aminotransferase (AST): • Male: 10 to 40 int. unit/L • Female: 9 to 32 int. unit/L
  • 3. Liver Enzymes Serum aminotransferases: alanine aminotransferase (ALT, formerly called SGPT) aspartate aminotransferase (AST, formerly called SGOT) Alkaline phosphatase (Alk Phos) Gamma-glutamyl transpeptidase (GGT) 5'-nucleotidase Lactate dehydrogenase (LDH)
  • 4. First step is transamination, where amino group is transferred a-KG Products are alpha-keto acid (derived from the original amino acid) and glutamate. Glutamate produced by transamination can be oxidatively deaminated, or used as an amino group donor in the synthesis of nonessential amino acids. Transaminases are in the cytosol and mitochondria of cells throughout the body – (esp: liver, kidney, intestine, and muscle). All amino acids, with the exception of lysine and threonine, participate in transamination at some point in their catabolism.
  • 5.  Substrate specificity of aminotransferases:  Aminotransferases are named after the specific amino group donor,  Acceptor of the amino group is almost always a-KG.  Two most important aminotransferase reactions are catalyzed by alanine aminotransferase (ALT) and aspartate aminotransferase(AST  Alanine aminotransferase (ALT) (glutamate-pyruvate transaminase)  ALT is present in many tissues. HOWEVER IT IS SPECIFIC FOR LIVER (unlike AST which is present in many tissues including muscle). THUS elevations in ALT are more specific for liver than AST.  Catalyzes transfer of the amino group of alanine to a-KG, resulting in the formation of pyruvate and glutamate.  Reversible  During amino acid catabolism, this enzyme functions in the direction of glutamate synthesis.  Glutamate, in effect, acts as a “collector” of nitrogen from alanine.  Transfer of amino group between alanine and alpha keto acid forming Pyruvate and Glutamate
  • 6.
  • 7. Aspartate aminotransferase (AST): AST is an exception to the rule that aminotransferases direct amino groups to form glutamate. AST transfers amino groups from glutamate to oxaloacetate (forming aspartate), which is used as a source of nitrogen in the urea cycle. Reversible Transfer of amino group between aspartate and alpha keto acid forming OA and Glutamate. Aspartate used in the urea cycle.
  • 8.
  • 9. Liver Disease Aminotransferases are intracellular enzymes Low levels found in the plasma represent the release of cellular contents during normal cell turnover. Elevated plasma levels of aminotransferases indicates damage to cells rich in these enzymes.
  • 10. AST:ALT Ratio Most causes of hepatocellular injury are associated with an AST that is lower than the ALT. Normal AST/ALT is 1.3 AST to ALT ratio of 2:1 or greater suggests alcoholic liver disease, particularly in the setting of an elevated GGT. Nonalcoholic steatohepatitis - AST to ALT ratio is elevated in an alcoholic liver disease pattern in patients Alcoholic liver disease – Elevated Hepatitis C - Elevated In addition, patients with Wilson disease or cirrhosis (viral hepatitis) may have AST>ALT, though in patients with cirrhosis the ratio typically is not greater than two.
  • 11. Magnitude of AST and ALT elevations  Magnitude of AST and ALT elevations varies due to cause of hepatocellular injury  Alcoholic fatty liver disease: AST <8 times the upper limit of normal; ALT <5 times the upper limit of normal  Nonalcoholic fatty liver disease: AST and ALT <4 times the upper limit of normal  Ischemic hepatopathy (ischemic hepatitis, shock liver): AST and ALT >50 times the upper limit of normal (in addition the lactate dehydrogenase is often markedly elevated)  Acute viral hepatitis or toxin-related hepatitis with jaundice: AST and ALT >25 times upper limit of normal  Chronic hepatitis C: Wide variability, typically normal to less than twice the upper limit of normal, rarely more than 10 times the upper limit of normal  Chronic hepatitis B: Levels fluctuate; the AST and ALT may be normal, though most patients have mild to moderate elevations (approximately twice the upper limit of normal); with exacerbations, levels are more than 10 times the upper limit of normal
  • 12. References  Cohen JA, Kaplan MM. The SGOT/SGPT ratio--an indicator of alcoholic liver disease. Dig Dis Sci 1979;  Fuchs S, Bogomolski-Yahalom V, Paltiel O, Ackerman Z. Ischemic hepatitis: clinical and laboratory observations of 34 patients. J Clin Gastroenterol 1998; 26:183  Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am J Gastroenterol 1992; 87:831.  Henrion J, Schapira M, Luwaert R, et al. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 2003; 82:392.  Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45:507  Ruhl CE, Everhart JE. Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology 2012; 55:447.